Evaluation of Nanocurcumin Effects on Depressive‐Like Behaviors in Rats and Determination of Serum BDNF and Serotonin Levels
Brain and Behavior · 2025
DOI: 10.1002/brb3.70320 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2025. Verfasst von Mahsa Hadipour Jahromi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Tehran Medical Science Branch, Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Serotonin, Antidepressive Agents, Depression. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Major depressive disorder (MDD) is a highly prevalent psychiatric condition worldwide, and it is the leading cause of disability globally. Turmeric, an aromatic perennial herb widely used in traditional Asian medicine and cuisine, contains curcumin, which has several biological effects, including a pseudoantidepressant effect. However, curcumin's low bioavailability limits its effectiveness. This study evaluated nanocurcumin (NCUR) effects on depressive‐like behaviors and examined serum BDNF and serotonin levels in a chronic stress model in rats. Behavioral assessments and biochemical indicators elucidated NCUR's antidepressant‐like properties.
Methods
In this experimental study, 30 adult male rats were randomly divided into six groups and exposed to unexpected chronic mild stress (UCMS). The groups included: control (CG), stress control (SCG), fluoxetine (FLU) treatment (20 mg/kg), and three NCUR doses (20, 40, and 80 mg/kg). Before UCMS exposure, rats underwent a sucrose preference test (SPT). Depressive behaviors were then assessed using the open field test (OFT), forced swimming test (FST), and tail suspension test (TST) on days 27 and 28. Blood samples were collected on day 28 to measure serum Brain derived neurotrophic factor (BDNF) and serotonin levels using enzyme‐linked immunosorbent assay (ELISA).
Results
NCUR treatment significantly alleviated depressive‐like behaviors in stressed rats. The sucrose preference index of the SCG decreased after 26 days of stress, while NCUR (all doses) and FLU reversed this effect. In the FST and TST, immobility time was significantly reduced in the NCUR and FLU groups compared to the SCG ( p < 0.05). The OFT also showed that the SCG had significantly fewer crossings compared to treated groups ( p < 0.05). Additionally, NCUR treatment significantly increased serum BDNF and serotonin levels compared to the SCG.
Conclusions
This study demonstrates that NCUR exerts antidepressant‐like effects, improving depressive behaviors and increasing BDNF and serotonin levels in rats exposed to chronic stress. NCUR may offer a promising alternative for the treatment of MDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Tehran Medical Science Branch, Islamic Azad University, Tehran, Iran.
- Maternal, Fetal and Neonatal Health Research Center, Institute of Family Health, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Mahsa Hadipour Jahromi, Hasti Charousaei
Zitieren
APA
Jahromi, M. H., Charousaei, H., & Charousaei, A. (2025). Evaluation of Nanocurcumin Effects on Depressive‐Like Behaviors in Rats and Determination of Serum BDNF and Serotonin Levels. Brain and Behavior. https://doi.org/10.1002/brb3.70320
Vancouver
Jahromi MH, Charousaei H, Charousaei A. Evaluation of Nanocurcumin Effects on Depressive‐Like Behaviors in Rats and Determination of Serum BDNF and Serotonin Levels. Brain and Behavior. 2025. doi:10.1002/brb3.70320
BibTeX
@article{Jahromi2025,
author = {Jahromi, Mahsa Hadipour and Charousaei, Hasti and Charousaei, Ali},
title = {Evaluation of Nanocurcumin Effects on Depressive‐Like Behaviors in Rats and Determination of Serum BDNF and Serotonin Levels},
journal = {Brain and Behavior},
year = {2025},
doi = {10.1002/brb3.70320}
}
EUVIMED